CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers
暂无分享,去创建一个
Lei Tang | Jian He | Yue Guan | Zhengyang Zhou | Weifeng Li | Yun Ge | Song Liu | C. Ji | Hua Shi | Zhengyang Zhou | Y. Ge | Lei Tang | Shunli Liu | Jian He | Shunli Liu | Hua Shi | Changfeng Ji | Wenxian Guan | Ling Chen | Yingshi Sun | Song Liu | W. Guan | Y. Guan | Weifeng Li | Ling Chen | Yingshi Sun
[1] Perry J Pickhardt,et al. CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.
[2] Y. Doki,et al. Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer , 2015, European Radiology.
[3] W. Kim,et al. Low Ki‐67 proliferation index is an indicator of poor prognosis in gastric cancer , 2010, Journal of surgical oncology.
[4] Xin He,et al. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis , 2014, BMC Cancer.
[5] V. Goh,et al. Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. , 2013, Radiology.
[6] Kui-Sheng Chen,et al. Spectral computed tomography in advanced gastric cancer: Can iodine concentration non-invasively assess angiogenesis? , 2017, World journal of gastroenterology.
[7] Alan D. Lopez,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.
[8] V. Goh,et al. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. , 2013, Radiology.
[9] E. Fishman,et al. Hypervascular gastric masses: CT findings and clinical correlates. , 2010, AJR. American journal of roentgenology.
[10] H. Honda,et al. Extent of arterial tumor enhancement measured with preoperative MDCT gastrography is a prognostic factor in advanced gastric cancer after curative resection. , 2013, AJR. American journal of roentgenology.
[11] R. Sutradhar,et al. A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer , 2012, Gastric Cancer.
[12] Z. Wang,et al. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[13] Yihong Sun,et al. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. , 2010, World journal of gastroenterology.
[14] P. Kim,et al. Gastric cancer staging at multi-detector row CT gastrography: comparison of transverse and volumetric CT scanning. , 2005, Radiology.
[15] Francesco Giganti,et al. Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker , 2017, European Radiology.
[16] Jian He,et al. Application of CT texture analysis in predicting histopathological characteristics of gastric cancers , 2017, European Radiology.
[17] Gerhard Christofori,et al. A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.
[18] Dan Zhou,et al. [Correlation of CT presentation with histo-differentiation and p53 and Ki67 expressions in gastric cancer]. , 2011, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.
[19] F. Giganti,et al. Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography , 2015, Gastric Cancer.
[20] Alejandro Munoz del Rio,et al. CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes , 2015, Abdominal Imaging.
[21] J. Gerdes. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. , 1990, Seminars in cancer biology.
[22] F. Roviello,et al. Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. , 2016, Cancer letters.
[23] Jie Ma,et al. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer , 2014, Medical Oncology.
[24] Sang Joon Park,et al. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. , 2016, European journal of radiology.
[25] Nicola Schieda,et al. Can Quantitative CT Texture Analysis be Used to Differentiate Fat-poor Renal Angiomyolipoma from Renal Cell Carcinoma on Unenhanced CT Images? , 2015, Radiology.
[26] R. Thornhill,et al. Quantitative CT texture and shape analysis: Can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? , 2015, European Radiology.
[27] R. Wirtz,et al. The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer , 2012, BMC Cancer.
[28] Vicky Goh,et al. Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? , 2013, European journal of radiology.
[29] S. Kobayashi,et al. Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data. , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[30] Francesco Giganti,et al. Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology. , 2017, European journal of radiology.
[31] Richard D. White,et al. CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung. , 2015, AJR. American journal of roentgenology.
[32] M. Naghavi,et al. Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden-Reply. , 2017, JAMA oncology.
[33] Yongfei Wang,et al. The prognostic value of E‐cadherin in gastric cancer: A meta‐analysis , 2013, International journal of cancer.
[34] Y. Saito,et al. Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma. , 2000, Gynecologic oncology.
[35] Y. Yatabe,et al. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer , 2010, The FEBS journal.
[36] M. Anzidei,et al. Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates. , 2017, Clinical radiology.
[37] M. Huang,et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. , 2003, Cancer letters.
[38] Mohammad Hossein Khosravi,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 , 2018, JAMA oncology.
[39] Z. Chang,et al. Relationship between expression of EGFR in gastric cancer tissue and clinicopathological features. , 2013, Asian Pacific journal of tropical medicine.
[40] L. Ellis,et al. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] F. Schmidt. Meta-Analysis , 2008 .
[42] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[43] C. Fuchs,et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial , 2014, The Lancet.